Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

News-breaking molecule: the first and only reported potent inhibitor of human asparagine synthase

Oct. 9, 2003

Antitumor efficacy and safety of arzoxifene in advanced endometrial cancer

Oct. 8, 2003

Sequential combination therapy reported effective in advanced follicular lymphoma

Oct. 8, 2003

Arius and PDL enter cancer antibody development partnership

Oct. 6, 2003

Rolling NDA submission continues for RSR-13

Oct. 6, 2003

Bayer presents two novel series of antitumor agents in recent patent literature

Oct. 6, 2003

Abraxane exceeds primary efficacy objective in phase III trial

Oct. 6, 2003

Phase III protocol for STR in multiple myeloma agreed under SPA

Oct. 3, 2003

Schering-Plough acquires rights to palonosetron

Oct. 3, 2003

European CPMP hands down positive opinion for Zevalin

Oct. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...